These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35949606)

  • 41. An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma.
    Zhang D; Zhang X; Liu Z; Han T; Zhao K; Xu X; Zhang X; Ren X; Qin C
    Front Oncol; 2023; 13():1207068. PubMed ID: 37427103
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma.
    Zhang Z; Tang Y; Liu Y; Zhuang H; Lin E; Xie L; Feng X; Tian K; Zeng J; Liu J; Yu Y
    J Immunol Res; 2021; 2021():9921466. PubMed ID: 34368371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
    Yang H; Han M; Li H
    Front Oncol; 2020; 10():707. PubMed ID: 32432045
    [No Abstract]   [Full Text] [Related]  

  • 44. Construction of an immune-related prognostic model by exploring the tumor microenvironment of clear cell renal cell carcinoma.
    He J; Zhong Y; Sun Y; Xie C; Yu T
    Anal Biochem; 2022 Apr; 643():114567. PubMed ID: 35122734
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression signature of six-snoRNA serves as novel non-invasive biomarker for diagnosis and prognosis prediction of renal clear cell carcinoma.
    Zhao Y; Yan Y; Ma R; Lv X; Zhang L; Wang J; Zhu W; Zhao L; Jiang L; Zhao L; Wen L; Yang B; Chen Y; He M; Liu M; Wei M
    J Cell Mol Med; 2020 Feb; 24(3):2215-2228. PubMed ID: 31943775
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioinformatics profiling integrating a three immune-related long non-coding RNA signature as a prognostic model for clear cell renal cell carcinoma.
    Jiang Y; Gou X; Wei Z; Tan J; Yu H; Zhou X; Li X
    Cancer Cell Int; 2020; 20():166. PubMed ID: 32435157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics.
    Zhang S; Xu X; Wang Y; Zhu Y; Wang J; Wang H; Guo J
    Ann Clin Lab Sci; 2021 Sep; 51(5):597-608. PubMed ID: 34686501
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
    Peng Y; Greenland NY; Lang UE; Stohr BA
    Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Mitochondrial Dysfunction and Oxidative Stress Pathway-Based Prognostic Signature for Clear Cell Renal Cell Carcinoma.
    Wu Y; Zhang X; Wei X; Feng H; Hu B; Deng Z; Liu B; Luan Y; Ruan Y; Liu X; Liu Z; Liu J; Wang T
    Oxid Med Cell Longev; 2021; 2021():9939331. PubMed ID: 34868460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of hazard immune-related genes and tumor immune infiltrations in renal cell carcinoma.
    Chen H; Xie J; Jin P
    Am J Transl Res; 2020; 12(11):7096-7113. PubMed ID: 33312353
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comprehensive analysis of new prognostic signature based on ferroptosis-related genes in clear cell renal cell carcinoma.
    Zheng B; Niu Z; Si S; Zhao G; Wang J; Yao Z; Cheng F; He W
    Aging (Albany NY); 2021 Aug; 13(15):19789-19804. PubMed ID: 34370716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic Immunophenotyping Clusters of Clear Cell Renal Cell Carcinoma Defined by the Unique Tumor Immune Microenvironment.
    Xu W; Anwaier A; Ma C; Liu W; Tian X; Su J; Zhu W; Shi G; Wei S; Xu H; Qu Y; Ye D; Zhang H
    Front Cell Dev Biol; 2021; 9():785410. PubMed ID: 34938737
    [No Abstract]   [Full Text] [Related]  

  • 53. Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma.
    Zhong M; Wang X; Zhu E; Gong L; Fei L; Zhao L; Wu K; Tang C; Zhang L; Wang Z; Zheng Z
    Front Genet; 2022; 13():905051. PubMed ID: 35846134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.
    Zeng JH; Lu W; Liang L; Chen G; Lan HH; Liang XY; Zhu X
    J Transl Med; 2019 Aug; 17(1):281. PubMed ID: 31443717
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of an Autophagy-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma.
    Chen M; Zhang S; Nie Z; Wen X; Gao Y
    Front Oncol; 2020; 10():873. PubMed ID: 32547955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic Value of Metabolism-Related Genes and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
    Li H; Mo Z
    Int J Gen Med; 2021; 14():6885-6898. PubMed ID: 34703293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Novel Prognostic Ferroptosis-Related Long Noncoding RNA Signature in Clear Cell Renal Cell Carcinoma.
    Bai Z; Zhao Y; Yang X; Wang L; Yin X; Chen Y; Lu J
    J Oncol; 2022; 2022():6304824. PubMed ID: 35242188
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systematic Construction and Validation of a Novel Macrophage Differentiation-Associated Prognostic Model for Clear Cell Renal Cell Carcinoma.
    Liu C; Zhang X; Hu C; Liang X; Cao X; Wang D
    Front Genet; 2022; 13():877656. PubMed ID: 35774505
    [No Abstract]   [Full Text] [Related]  

  • 59. Identification of an apoptosis-related prognostic gene signature and molecular subtypes of clear cell renal cell carcinoma (ccRCC).
    Zhong W; Zhang F; Huang C; Lin Y; Huang J
    J Cancer; 2021; 12(11):3265-3276. PubMed ID: 33976736
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma.
    Wang Q; Tang H; Luo X; Chen J; Zhang X; Li X; Li Y; Chen Y; Xu Y; Han S
    Front Immunol; 2022; 13():890150. PubMed ID: 35686121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.